Is b-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? data from the heart and soul study
Authors:
- Maria AnsariMAMaria Ansari
- Nelson B. SchillerNSNelson B. Schiller
- Barry MassieBMBarry Massie
- Mary A. WhooleyMWMary A. Whooley
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (8) , 509-516
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary DiseaseCirculation, 2003
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart FailureCirculation, 2002
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the communityHeart, 2000
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Heart, 1996
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.Journal of Clinical Investigation, 1995
- Pitfalls in the Echo‐Doppler Assessment of Diastolic DysfunctionEchocardiography, 1993